Glycosylation of Natural and Recombinant Antibody Molecules

1. Jefferis, R., Lund, J. & Pound, J. (1998) IgG-Fc mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol.Rev. 163:50–76.

   Article  Google Scholar 

2. Jefferis, R. (2001) Glycosylation of human IgG antibodies: relevance to therapeutic applications. Biopharm. 14:19–26.

   CAS  Google Scholar 

3. Jefferis, R. and Lund, J. (2002) Interaction sites on human IgG-Fc for FcγR: current models. Immunol.Lett. 82:57–65.

   Article  CAS  PubMed  Google Scholar 

4. Jefferis, R. (2005) Glycosylation of Recombinant Antibody Therapeutics. Biotechnology Progress. In press.

   Google Scholar 

5. Dunn-Walters D.; Boursier L.; Spencer J.(2000) Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Molecular Immunology. 37:107–13.

   Article  CAS  PubMed  Google Scholar 

6. Deisenhofer, J., (1981) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-Å resolution. Biochemistry 20:2361–2370.

   Article  CAS  PubMed  Google Scholar 

7. Jefferis, R, Lund, J, Mizitani, H, Nakagawa, H, Kawazoe, Y, Arata, Y & Takahashi, N. (1990) A comparative study of the N-linked Oligosaccharide structures of human IgG subclass proteins. Biochem. J. 268, 529–537.

   Article  CAS  PubMed  PubMed Central  Google Scholar 

8. Malhotra. R.; Wormald, M. R.; Rudd, P. M.; Fischer, P. B.; Dwek, R. A.; Sim R. B. (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine. 1, 237–243.

   Article  CAS  PubMed  Google Scholar 

9. Abadeh, S., Church, S., Dong, S., Lund, J., Goodall, M. and Jefferis R. (1997) Remodelling the oligosaccharide of human IgG antibodies: effects on biological activities. Biochem. Soc. Trans. 25:S661

   Article  CAS  PubMed  Google Scholar 

10. Dong, X.; Storkus, W. J.; Salter, R. D. (1999) Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J.Immunol. 163, 5427–5434.

    CAS  PubMed  Google Scholar 

11. http://www.fda.gov/cder/biologics/review/ritugen112697-r2.pdf

    Google Scholar 

12. Kibe, T., Fujimoto, S., Ishida, C., Togari, H., Okada, S., Nalagawa, H., Tsukamoto, Y Takahashi, N. (1996) Glycosylation and placental transport of IgG. J.Clin.Biochem.Nutrition. 21:57–63.

    Article  CAS  Google Scholar 

13. Umana, P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE. (1998) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol. 17:176–80.

    Google Scholar 

14. Davies, J., Jiang, L., LaBarre, MJ., Anderson, D., Reff, M. (2001) Expression of GTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies of altered glycoforms leads to an increase in ADCC thro’ higher affinity for FcRIII. Biotech. Bioeng. 74:288–294.

    Article  CAS  Google Scholar 

15. Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Meng YG, Weikert SH, Presta LG. (2002) Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human Fcgamma RIII and Antibody-dependent Cellular Toxicity. J. Biol Chem. 277:26733–40.

    Article  CAS  PubMed  Google Scholar 

16. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K. (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 278:3466–73.

    Article  CAS  PubMed  Google Scholar 

17. Okazaki A, Shoji-Hosaka E, Nakamura K, Wakitani M, Uchida K, Kakita S, Tsumoto K, Kumagai I, Shitara K. (2004) Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and Fcgamma RIIIa. J Mol Biol. 336:1239–49.

    Article  CAS  PubMed  Google Scholar 

18. Jassal, R., Jenkins, N., Charlwood, J., Camilleri, P., Jefferis, R. and Lund, J. (2001) Sialylation of human IgG-Fc carbohydrate by transfected rat α(2–6) sialyltransferase. Biochem. Biophys.Res.Comm. 286:243–249.

    Article  CAS  PubMed  Google Scholar 

19. Mimura Y., Church S., Ghirlando R,. Dong S., Goodall M., Lund J. and Jefferis R. (2000) The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Molecular Immunology. 37:697–706.

    Article  CAS  PubMed  Google Scholar 

20. Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S.P., Goodall, M. and Jefferis, R. (2001). The role of oligosaccharide residues of IgG1-Fc in FcγIIb binding. J.Biol.Chem. 276:45539–45547.

    Article  CAS  PubMed  Google Scholar 

21. Krapp, S., Mimura, Y., Jefferis, R., Huber, R. and Sondermann, P. (2003) Structural analysis of human IgG glycoforms reveals a correlation between oligosaccharide content, structural integrity and Fcγ-receptor affinity. J.Mol.Biol. 325:979–989.

    Article  CAS  PubMed  Google Scholar 

22. Lund, J., Winter, G., Jones, P.T., Pound, J., Tanaka, T., Walker, M.R., Artymiuk, P.J., Arata, Y., Burton, D.R., Jefferis, R. and Woof, J.M. (1991) Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J. Immunol. 147 2657–2662.

    CAS  PubMed  Google Scholar 

23. Sondermann P. Huber R. Oosthuizen V. Jacob U. (2000). The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature. 406(6793):267–273.

    Article  CAS  PubMed  Google Scholar 

24. Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD. (2001) The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem. 276:16469–77.

    Article  CAS  PubMed  Google Scholar 

25. Youings, A.; Chang, S. C.; Dwek, R. A.; Scragg, I. G. (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J. 314, 621–30.

    Article  PubMed  PubMed Central  Google Scholar 

26. Holland, M., Takada, K., Okomoto, T., Takahashi, N., Kato, K., Adu, D., Ben-Smith, A., Harper, L., Savage, C.O.S. and Jefferis, R. (2002) Hypogalactosylation of serum IgG in patients with ANCAassociated systemic vasculitis. Clin. exp. Immunol. 129:183–190.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references